Search Results 1501-1510 of 21417 for anti-TNF drugs

1. Lobular Carcinoma In Situ (LCIS) Clinical Trials - Mayo Clinic Research

   The purpose of this research study is to test whether metformin, a drug commonly used to treat diabetes, is able to get rid of atypia (early cell changes that ...

2. Gene Therapy Clinical Trials - Mayo Clinic Research

   This pivotal, open-label, single-arm study will evaluate the anti-cancer activity of ARQ 087 by Objective Response Rate (ORR) by central radiology review as per ...

3. Sulfamethoxazole And Trimethoprim (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. Tinidazole (Oral Route) Description and Brand Names - Mayo Clinic

   These medicines are used to treat infections caused by protozoa (tiny, one-celled animals). This medicine is available only with your doctor's prescription.

5. A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety - Mayo Clinic

   The purpose of the study is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to other anti-hypertensive drugs of patients ...

6. A Study of the Safety and Usability of Culture Expanded STEM Cells Derived from the Patient's Own Fat Tissue for Treatment of Knee Osteoarthritis - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Taking non-steroidal anti-inflammatory medications (e.g., COX-2 inhibitors) ...

7. Postherpetic neuralgia - Symptoms and causes - Mayo Clinic

   Often the pain starts before you notice a rash. The risk of postherpetic neuralgia becomes lower if you start taking virus-fighting medicines called antivirals ...

8. An Expansion Study to Evaluate Dose Escalation, Safety and Tolerability of SAR444881 in Patients with Advanced Solid Tumors - Mayo Clinic

   * Cytotoxic/Non-cytotoxic anti-cancer agents, unless at least 4 weeks have elapsed from last dose * Use of other investigational drugs within 28 days * ...

9. ALTTO Test of Dual HER2 Blockade Finds Single Agent - Trastuzumab - Remains Gold Standard - Mayo Clinic News Network

   ... anti-HER2 agents would provide more benefit compared to single anti-HER2 therapy.” Dr. Perez added that the findings were additionally disappointing in that ...

10. Umeclidinium And Vilanterol (Inhalation Route) Description and Brand Names - Mayo Clinic

    Inhaled umeclidinium is an anticholinergic. Inhaled vilanterol is a long-acting bronchodilator. Bronchodilators are medicines that are breathed in through the ...